Korro Bio Completes $116M Series B Financing to Expand the Frontier of Genetic Medicine Through Its Pipeline of RNA Editing Programs
This Stem Cell Manufacturing Startup Just Raised An $80 Million War Chest To Revolutionize Medicine
Totus Medicines Emerges from Stealth with Revolutionary Drug Program Targeting PI3K-Alpha Oncogene
Elevian Raises $40 Million Series A to Advance Treatments for Stroke Recovery and Age-Related Diseases
Acrivon Therapeutics Closes Oversubscribed $100 Million Series B Financing to Advance its Innovative Precision Proteomics Platform and Clinical Oncology Pipeline
Lilly, Pfizer-backed Arkuda bags $64M to test drug in frontotemporal dementia in 2023
Seismic Therapeutic Launches with $101 Million Series A Financing to Usher in a New Era of Immunology Drug Development Integrating Machine Learning
Engitix Nets $54M for Human Extracellular Matrix Drug Targets
Twice Rejected Diabetes Drug/Device Product Gets New Chance at Startup i2o
Lucy Therapeutics Expands Cutting-Edge Medical Research Program
